Longevity Vision Fund Announces Series B Investment into Exo Imaging

Longevity Vision Fund, a $100M life extension-focused fund founded by longevity investor and visionary Sergey Young announced the completion of a Series B investment round into Exo Imaging.

This brings Exo Imaging’s latest fundraising total to nearly $50 million since its launch in 2015. Along Longevity Vision Fund, investments were also made by Applied Ventures, Bold Capital, Creative Ventures, Intel Capital, Magnetar Capital, Nautilus Venture Partners, OSF Healthcare, Rising Tide Fund, Sony Innovation Fund and Wanxiang Healthcare Investments.

Co-founded by Sandeep Akkaraju, Exo Imaging is a California-based medical imaging startup that develops ultrasound systems with the goal of providing physicians a single, handheld probe that can be used for the entire body—from observing the heart and other organs to imaging a person’s vasculature or skeletal features in 3D.

“Longevity Vision Fund is excited to have made another step in its mission for affordable and accessible longevity by supporting Exo Imaging in developing portable and inexpensive ultrasound device solutions. We have every faith Exo Imaging will be successful in disrupting the current ultrasound imaging market” said Sergey Young, Founder of Longevity Vision Fund.

Exo Imaging Co-founder and CEO Sandeep Akkaraju said the Series B financing will be used to advance the company’s FDA 510(k) clearance process into commercialization and to build its team of engineering, sales and operations professionals.

exo.png